Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | d138931dex312.htm |
| EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | d138931dex311.htm |
| EX-32.1 - EX-32.1 - Larimar Therapeutics, Inc. | d138931dex321.htm |
| EX-10.16 - EX-10.16 - Larimar Therapeutics, Inc. | d138931dex1016.htm |
| 10-K - 10-K - Larimar Therapeutics, Inc. | d138931d10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-8 (File Nos. 333-196900 and 333-204931) of Zafgen, Inc. of our report dated March 15, 2016 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 15, 2016